

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.56894450 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.56894450 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.26726324 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.26726324 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.95487239 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.42355990 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.42355990 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.42355990 |
| 9 | kynurenine metabolic process (GO:0070189) | 6.17973431 |
| 10 | glyoxylate metabolic process (GO:0046487) | 6.06564214 |
| 11 | tryptophan metabolic process (GO:0006568) | 6.02780251 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.95524623 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.90865379 |
| 14 | cysteine metabolic process (GO:0006534) | 5.65542996 |
| 15 | urea metabolic process (GO:0019627) | 5.49346322 |
| 16 | urea cycle (GO:0000050) | 5.49346322 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.40440537 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.37632852 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.33675425 |
| 20 | epoxygenase P450 pathway (GO:0019373) | 5.29402609 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.25260654 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 5.25042711 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.20990477 |
| 24 | protein carboxylation (GO:0018214) | 5.18371571 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.18371571 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.17443237 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.17022449 |
| 28 | lysine metabolic process (GO:0006553) | 5.10259968 |
| 29 | lysine catabolic process (GO:0006554) | 5.10259968 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.09678383 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.06536770 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 5.05853372 |
| 33 | bile acid metabolic process (GO:0008206) | 5.03388177 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.88252964 |
| 35 | regulation of complement activation (GO:0030449) | 4.83516347 |
| 36 | tyrosine metabolic process (GO:0006570) | 4.72825091 |
| 37 | amino-acid betaine metabolic process (GO:0006577) | 4.72266345 |
| 38 | alpha-amino acid catabolic process (GO:1901606) | 4.71426264 |
| 39 | regulation of lipoprotein metabolic process (GO:0050746) | 4.69959554 |
| 40 | ethanol metabolic process (GO:0006067) | 4.69684306 |
| 41 | negative regulation of protein activation cascade (GO:2000258) | 4.66933244 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.63316245 |
| 43 | negative regulation of complement activation (GO:0045916) | 4.62545238 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.56011727 |
| 45 | sodium-independent organic anion transport (GO:0043252) | 4.55650095 |
| 46 | indolalkylamine metabolic process (GO:0006586) | 4.53844547 |
| 47 | reverse cholesterol transport (GO:0043691) | 4.53015088 |
| 48 | cellular ketone body metabolic process (GO:0046950) | 4.49509034 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.49280824 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.49280824 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.49280824 |
| 52 | purine nucleotide transport (GO:0015865) | 4.48366589 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.44915563 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.44915563 |
| 55 | amine catabolic process (GO:0009310) | 4.43482116 |
| 56 | cellular biogenic amine catabolic process (GO:0042402) | 4.43482116 |
| 57 | triglyceride homeostasis (GO:0070328) | 4.39676921 |
| 58 | acylglycerol homeostasis (GO:0055090) | 4.39676921 |
| 59 | primary alcohol catabolic process (GO:0034310) | 4.39315929 |
| 60 | coenzyme catabolic process (GO:0009109) | 4.38138230 |
| 61 | phenylpropanoid metabolic process (GO:0009698) | 4.37507466 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 4.36893920 |
| 63 | glycine metabolic process (GO:0006544) | 4.36074134 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 4.35783534 |
| 65 | glutamate metabolic process (GO:0006536) | 4.35693846 |
| 66 | cellular glucuronidation (GO:0052695) | 4.33245742 |
| 67 | phospholipid efflux (GO:0033700) | 4.29897868 |
| 68 | oxidative demethylation (GO:0070989) | 4.28895586 |
| 69 | bile acid and bile salt transport (GO:0015721) | 4.27550219 |
| 70 | drug catabolic process (GO:0042737) | 4.25095838 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 4.24771650 |
| 72 | positive regulation of chemokine secretion (GO:0090197) | 4.23835383 |
| 73 | ethanol oxidation (GO:0006069) | 4.19133393 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 4.16217957 |
| 75 | hormone catabolic process (GO:0042447) | 4.14920221 |
| 76 | plasma lipoprotein particle clearance (GO:0034381) | 4.14833776 |
| 77 | serine family amino acid biosynthetic process (GO:0009070) | 4.12332070 |
| 78 | biotin metabolic process (GO:0006768) | 4.05153361 |
| 79 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.04788680 |
| 80 | urate metabolic process (GO:0046415) | 4.04731301 |
| 81 | * benzene-containing compound metabolic process (GO:0042537) | 4.03337357 |
| 82 | aldehyde catabolic process (GO:0046185) | 4.02978545 |
| 83 | drug metabolic process (GO:0017144) | 4.02580107 |
| 84 | drug transmembrane transport (GO:0006855) | 4.01949514 |
| 85 | cholesterol efflux (GO:0033344) | 3.95608372 |
| 86 | retinal metabolic process (GO:0042574) | 3.94144940 |
| 87 | arginine metabolic process (GO:0006525) | 3.93648920 |
| 88 | uronic acid metabolic process (GO:0006063) | 3.90454857 |
| 89 | glucuronate metabolic process (GO:0019585) | 3.90454857 |
| 90 | ketone body metabolic process (GO:1902224) | 3.89253893 |
| 91 | omega-hydroxylase P450 pathway (GO:0097267) | 3.88960330 |
| 92 | fibrinolysis (GO:0042730) | 3.87400893 |
| 93 | acetyl-CoA metabolic process (GO:0006084) | 3.86118403 |
| 94 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.85955887 |
| 95 | organic acid catabolic process (GO:0016054) | 3.82486116 |
| 96 | carboxylic acid catabolic process (GO:0046395) | 3.82486116 |
| 97 | exogenous drug catabolic process (GO:0042738) | 3.81239576 |
| 98 | S-adenosylmethionine metabolic process (GO:0046500) | 3.81187746 |
| 99 | plasma lipoprotein particle assembly (GO:0034377) | 3.77591030 |
| 100 | low-density lipoprotein particle remodeling (GO:0034374) | 3.76137061 |
| 101 | aspartate family amino acid catabolic process (GO:0009068) | 3.73973823 |
| 102 | cofactor catabolic process (GO:0051187) | 3.72758016 |
| 103 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71841804 |
| 104 | negative regulation of humoral immune response (GO:0002921) | 3.70343864 |
| 105 | regulation of cholesterol homeostasis (GO:2000188) | 3.66798595 |
| 106 | regulation of plasminogen activation (GO:0010755) | 3.65647858 |
| 107 | complement activation, classical pathway (GO:0006958) | 3.64616791 |
| 108 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.63998709 |
| 109 | blood coagulation, intrinsic pathway (GO:0007597) | 3.63605106 |
| 110 | 2-oxoglutarate metabolic process (GO:0006103) | 3.63062761 |
| 111 | phospholipid homeostasis (GO:0055091) | 3.59929182 |
| 112 | complement activation (GO:0006956) | 3.59818741 |
| 113 | cytolysis (GO:0019835) | 3.59609242 |
| 114 | flavonoid metabolic process (GO:0009812) | 3.59194759 |
| 115 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59035968 |
| 116 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.57783646 |
| 117 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.57783646 |
| 118 | primary alcohol metabolic process (GO:0034308) | 3.57494032 |
| 119 | heme transport (GO:0015886) | 3.57009758 |
| 120 | regulation of chemokine secretion (GO:0090196) | 3.56871889 |
| 121 | positive regulation of lipid catabolic process (GO:0050996) | 3.56251127 |
| 122 | protein activation cascade (GO:0072376) | 3.56235478 |
| 123 | linoleic acid metabolic process (GO:0043651) | 3.55717429 |
| 124 | NAD biosynthetic process (GO:0009435) | 3.55465774 |
| 125 | carnitine metabolic process (GO:0009437) | 3.52898247 |
| 126 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.46759492 |
| 127 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.34155119 |
| 128 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.34155119 |
| 129 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.32531227 |
| 130 | drug transport (GO:0015893) | 3.30052623 |
| 131 | response to mercury ion (GO:0046689) | 3.25957785 |
| 132 | valine metabolic process (GO:0006573) | 3.21292140 |
| 133 | regulation of humoral immune response (GO:0002920) | 3.20856093 |
| 134 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.17751765 |
| 135 | branched-chain amino acid metabolic process (GO:0009081) | 3.16556249 |
| 136 | regulation of apoptotic cell clearance (GO:2000425) | 3.16256836 |
| 137 | monocarboxylic acid catabolic process (GO:0072329) | 3.10709382 |
| 138 | lung lobe morphogenesis (GO:0060463) | 3.05804342 |
| 139 | alkaloid metabolic process (GO:0009820) | 3.04203321 |
| 140 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.03080373 |
| 141 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.03080373 |
| 142 | * short-chain fatty acid metabolic process (GO:0046459) | 3.03046606 |
| 143 | negative regulation of hemostasis (GO:1900047) | 3.02365183 |
| 144 | negative regulation of blood coagulation (GO:0030195) | 3.02365183 |
| 145 | acute-phase response (GO:0006953) | 3.01594087 |
| 146 | * xenobiotic metabolic process (GO:0006805) | 3.01494916 |
| 147 | steroid catabolic process (GO:0006706) | 3.00963368 |
| 148 | lung vasculature development (GO:0060426) | 2.99874335 |
| 149 | * fatty acid oxidation (GO:0019395) | 2.97898962 |
| 150 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.97643131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.33463323 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.14587825 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.93257763 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.44038689 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.18302704 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.97798108 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.90598227 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97908476 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.97901932 |
| 10 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.54093648 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09980996 |
| 12 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.07315417 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.07139932 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05491313 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8445717 |
| 16 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.70671127 |
| 17 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.63730249 |
| 18 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61518435 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57852053 |
| 20 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.53751357 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.53443017 |
| 22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44666758 |
| 23 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44061340 |
| 24 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.42849281 |
| 25 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.41146436 |
| 26 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.32852128 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31760831 |
| 28 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.24598480 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24551968 |
| 30 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.22336368 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21815092 |
| 32 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.20846609 |
| 33 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18613341 |
| 34 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18472498 |
| 35 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.16549885 |
| 36 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16305731 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.15980977 |
| 38 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15577493 |
| 39 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.13628948 |
| 40 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.11915769 |
| 41 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.11668293 |
| 42 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09166368 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.09048473 |
| 44 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07554653 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07190262 |
| 46 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06638423 |
| 47 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.06368141 |
| 48 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.04676219 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03395957 |
| 50 | ERA_21632823_ChIP-Seq_H3396_Human | 1.01326016 |
| 51 | NFYA_21822215_ChIP-Seq_K562_Human | 1.01095886 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99929816 |
| 53 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98947367 |
| 54 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.98402346 |
| 55 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98370434 |
| 56 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.97979549 |
| 57 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.97806982 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97685535 |
| 59 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97484688 |
| 60 | TBL1_22424771_ChIP-Seq_293T_Human | 0.97294565 |
| 61 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96163927 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95273806 |
| 63 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.94179889 |
| 64 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.93032678 |
| 65 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.93030051 |
| 66 | NFYB_21822215_ChIP-Seq_K562_Human | 0.92597720 |
| 67 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.91898917 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91846948 |
| 69 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.91335232 |
| 70 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.91325505 |
| 71 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.90477161 |
| 72 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.89711402 |
| 73 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.89354211 |
| 74 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89229215 |
| 75 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.88639900 |
| 76 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.87420022 |
| 77 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.87327978 |
| 78 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.87069569 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86865269 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86788423 |
| 81 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86487208 |
| 82 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86344540 |
| 83 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85624113 |
| 84 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.84436425 |
| 85 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.82923987 |
| 86 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79098095 |
| 87 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78948318 |
| 88 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78189997 |
| 89 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77244788 |
| 90 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75981806 |
| 91 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73554858 |
| 92 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.72266070 |
| 93 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72153407 |
| 94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71590739 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71383347 |
| 96 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70348982 |
| 97 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.69583655 |
| 98 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68568007 |
| 99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68499878 |
| 100 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.67346324 |
| 101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67067763 |
| 102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67067763 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.66939791 |
| 104 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.65593984 |
| 105 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64368013 |
| 106 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63013689 |
| 107 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62668690 |
| 108 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61062533 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.59542043 |
| 110 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59411116 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59296181 |
| 112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58261554 |
| 113 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.56839810 |
| 114 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54540851 |
| 115 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54188111 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53016135 |
| 117 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52688841 |
| 118 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52066192 |
| 119 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51378192 |
| 120 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49056020 |
| 121 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48634727 |
| 122 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48344131 |
| 123 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.47993689 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.47236007 |
| 125 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45812748 |
| 126 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.45554483 |
| 127 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45082618 |
| 128 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.44902773 |
| 129 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44363555 |
| 130 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44176549 |
| 131 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43422646 |
| 132 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.43304535 |
| 133 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.42933263 |
| 134 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.42811078 |
| 135 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.42726102 |
| 136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.41839894 |
| 137 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41539797 |
| 138 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41246698 |
| 139 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.40823160 |
| 140 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.40806405 |
| 141 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40475399 |
| 142 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40367892 |
| 143 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40112798 |
| 144 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39646781 |
| 145 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39074333 |
| 146 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36651972 |
| 147 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.36616613 |
| 148 | NCOR_22424771_ChIP-Seq_293T_Human | 0.36019786 |
| 149 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.35940927 |
| 150 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35887543 |
| 151 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.35580248 |
| 152 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35121856 |
| 153 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.34993991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.37404546 |
| 2 | MP0005360_urolithiasis | 7.80881423 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.30558953 |
| 4 | MP0005365_abnormal_bile_salt | 6.08357872 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.11735188 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.13516004 |
| 7 | MP0003252_abnormal_bile_duct | 3.89228997 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.41524071 |
| 9 | MP0003183_abnormal_peptide_metabolism | 3.07590279 |
| 10 | MP0009840_abnormal_foam_cell | 3.02396935 |
| 11 | MP0005332_abnormal_amino_acid | 3.02306904 |
| 12 | MP0003195_calcinosis | 2.99657551 |
| 13 | MP0005083_abnormal_biliary_tract | 2.93397476 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.54678707 |
| 15 | MP0002132_abnormal_respiratory_system | 2.52024825 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.47232870 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.43552171 |
| 18 | MP0010386_abnormal_urinary_bladder | 2.25931046 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.25906177 |
| 20 | MP0003136_yellow_coat_color | 2.24528847 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.20729028 |
| 22 | MP0000609_abnormal_liver_physiology | 2.08514962 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 2.04664119 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.84759684 |
| 25 | MP0003868_abnormal_feces_composition | 1.79360957 |
| 26 | MP0005409_darkened_coat_color | 1.70573115 |
| 27 | MP0001188_hyperpigmentation | 1.70402156 |
| 28 | MP0001764_abnormal_homeostasis | 1.66141653 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60378649 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.50154919 |
| 31 | MP0009697_abnormal_copulation | 1.43008945 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.42868182 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.42868182 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.41271953 |
| 35 | MP0005451_abnormal_body_composition | 1.39411352 |
| 36 | MP0003186_abnormal_redox_activity | 1.34141153 |
| 37 | MP0005410_abnormal_fertilization | 1.29919369 |
| 38 | MP0003011_delayed_dark_adaptation | 1.27696700 |
| 39 | MP0005310_abnormal_salivary_gland | 1.27432025 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 1.15384018 |
| 41 | MP0000598_abnormal_liver_morphology | 1.14562009 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.12295328 |
| 43 | MP0004147_increased_porphyrin_level | 1.10196061 |
| 44 | MP0005647_abnormal_sex_gland | 1.09927727 |
| 45 | MP0009764_decreased_sensitivity_to | 1.06836852 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.06622959 |
| 47 | MP0000604_amyloidosis | 1.01798968 |
| 48 | MP0003879_abnormal_hair_cell | 0.99017882 |
| 49 | MP0009763_increased_sensitivity_to | 0.96417905 |
| 50 | MP0003866_abnormal_defecation | 0.95715066 |
| 51 | MP0004233_abnormal_muscle_weight | 0.91816412 |
| 52 | MP0002254_reproductive_system_inflammat | 0.90063787 |
| 53 | MP0008469_abnormal_protein_level | 0.89524490 |
| 54 | MP0003941_abnormal_skin_development | 0.88801823 |
| 55 | MP0009642_abnormal_blood_homeostasis | 0.88316451 |
| 56 | MP0005084_abnormal_gallbladder_morpholo | 0.88244065 |
| 57 | MP0010368_abnormal_lymphatic_system | 0.88023227 |
| 58 | MP0002735_abnormal_chemical_nociception | 0.87223768 |
| 59 | MP0002166_altered_tumor_susceptibility | 0.87168008 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 0.86010440 |
| 61 | MP0002876_abnormal_thyroid_physiology | 0.85309173 |
| 62 | MP0003045_fibrosis | 0.84188448 |
| 63 | MP0001944_abnormal_pancreas_morphology | 0.83983649 |
| 64 | MP0005670_abnormal_white_adipose | 0.83778922 |
| 65 | MP0005408_hypopigmentation | 0.83653315 |
| 66 | MP0001756_abnormal_urination | 0.80868070 |
| 67 | MP0009785_altered_susceptibility_to | 0.79136033 |
| 68 | MP0005376_homeostasis/metabolism_phenot | 0.76698007 |
| 69 | MP0000371_diluted_coat_color | 0.76169030 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 0.75601005 |
| 71 | MP0009765_abnormal_xenobiotic_induced | 0.75535674 |
| 72 | MP0005220_abnormal_exocrine_pancreas | 0.74832895 |
| 73 | MP0002089_abnormal_postnatal_growth/wei | 0.73995971 |
| 74 | MP0001727_abnormal_embryo_implantation | 0.72466513 |
| 75 | MP0002396_abnormal_hematopoietic_system | 0.71786917 |
| 76 | MP0005535_abnormal_body_temperature | 0.71608875 |
| 77 | MP0001661_extended_life_span | 0.70622899 |
| 78 | MP0002971_abnormal_brown_adipose | 0.68561564 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.67373758 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.66388712 |
| 81 | MP0001485_abnormal_pinna_reflex | 0.64256131 |
| 82 | MP0005334_abnormal_fat_pad | 0.64250829 |
| 83 | MP0003690_abnormal_glial_cell | 0.64170533 |
| 84 | MP0003329_amyloid_beta_deposits | 0.63634991 |
| 85 | MP0004043_abnormal_pH_regulation | 0.63286477 |
| 86 | MP0004130_abnormal_muscle_cell | 0.61780436 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.61632183 |
| 88 | MP0009053_abnormal_anal_canal | 0.61217353 |
| 89 | MP0005266_abnormal_metabolism | 0.61023355 |
| 90 | MP0005646_abnormal_pituitary_gland | 0.59687173 |
| 91 | MP0004885_abnormal_endolymph | 0.58980741 |
| 92 | MP0001664_abnormal_digestion | 0.58867965 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.57157560 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.57013525 |
| 95 | MP0003698_abnormal_male_reproductive | 0.56524150 |
| 96 | MP0002928_abnormal_bile_duct | 0.55387050 |
| 97 | MP0008995_early_reproductive_senescence | 0.54333648 |
| 98 | MP0000639_abnormal_adrenal_gland | 0.51449180 |
| 99 | MP0005395_other_phenotype | 0.50821170 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.50365630 |
| 101 | MP0001929_abnormal_gametogenesis | 0.49332227 |
| 102 | MP0005023_abnormal_wound_healing | 0.49324348 |
| 103 | MP0005448_abnormal_energy_balance | 0.48194494 |
| 104 | MP0005464_abnormal_platelet_physiology | 0.46510683 |
| 105 | MP0003724_increased_susceptibility_to | 0.44984021 |
| 106 | MP0001765_abnormal_ion_homeostasis | 0.44876555 |
| 107 | MP0008874_decreased_physiological_sensi | 0.44167642 |
| 108 | MP0003718_maternal_effect | 0.41774283 |
| 109 | MP0003953_abnormal_hormone_level | 0.41274097 |
| 110 | MP0008873_increased_physiological_sensi | 0.41259857 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.41181625 |
| 112 | MP0002822_catalepsy | 0.41055972 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.40554750 |
| 114 | MP0005058_abnormal_lysosome_morphology | 0.39672664 |
| 115 | MP0003075_altered_response_to | 0.39448878 |
| 116 | MP0002168_other_aberrant_phenotype | 0.38863816 |
| 117 | MP0005166_decreased_susceptibility_to | 0.38299079 |
| 118 | MP0002796_impaired_skin_barrier | 0.37807929 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.37643254 |
| 120 | MP0003436_decreased_susceptibility_to | 0.36267978 |
| 121 | MP0009672_abnormal_birth_weight | 0.35633418 |
| 122 | MP0008872_abnormal_physiological_respon | 0.35279338 |
| 123 | MP0004381_abnormal_hair_follicle | 0.35093711 |
| 124 | MP0002837_dystrophic_cardiac_calcinosis | 0.34724439 |
| 125 | MP0005248_abnormal_Harderian_gland | 0.34131433 |
| 126 | MP0000579_abnormal_nail_morphology | 0.33600236 |
| 127 | MP0009384_cardiac_valve_regurgitation | 0.32170629 |
| 128 | MP0006082_CNS_inflammation | 0.30609802 |
| 129 | MP0009115_abnormal_fat_cell | 0.30601625 |
| 130 | MP0002135_abnormal_kidney_morphology | 0.30109870 |
| 131 | MP0000249_abnormal_blood_vessel | 0.27839433 |
| 132 | MP0001845_abnormal_inflammatory_respons | 0.27674544 |
| 133 | MP0002970_abnormal_white_adipose | 0.27312453 |
| 134 | MP0004264_abnormal_extraembryonic_tissu | 0.27090513 |
| 135 | MP0000538_abnormal_urinary_bladder | 0.26648191 |
| 136 | MP0001881_abnormal_mammary_gland | 0.25134651 |
| 137 | MP0001853_heart_inflammation | 0.24327914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.23484561 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.15890681 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.02349427 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.44889521 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.20843443 |
| 6 | Xanthomatosis (HP:0000991) | 6.06505904 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.96996984 |
| 8 | Complement deficiency (HP:0004431) | 5.23590491 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.17741862 |
| 10 | Joint hemorrhage (HP:0005261) | 4.63589695 |
| 11 | Hyperammonemia (HP:0001987) | 4.62936435 |
| 12 | Hyperglycinemia (HP:0002154) | 4.53537369 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.48681146 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.45845527 |
| 15 | Ketosis (HP:0001946) | 4.44360263 |
| 16 | Severe visual impairment (HP:0001141) | 4.39779670 |
| 17 | Hyperglycinuria (HP:0003108) | 4.29942992 |
| 18 | Epidermoid cyst (HP:0200040) | 4.27494275 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.27218121 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.25754095 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.22195413 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.18312739 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 4.18312739 |
| 24 | Cerebral palsy (HP:0100021) | 4.18271086 |
| 25 | Seborrheic dermatitis (HP:0001051) | 4.17785350 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.07065351 |
| 27 | Fat malabsorption (HP:0002630) | 4.06902673 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 4.05080980 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 3.88709620 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.81010357 |
| 31 | Abnormality of complement system (HP:0005339) | 3.79319152 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.75015485 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.61892966 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.57718351 |
| 35 | Reduced antithrombin III activity (HP:0001976) | 3.56986568 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.50287257 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.38328218 |
| 38 | Ketoacidosis (HP:0001993) | 3.33217451 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.32443894 |
| 40 | Delayed CNS myelination (HP:0002188) | 3.31000075 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28602162 |
| 42 | Hyperbilirubinemia (HP:0002904) | 3.26029380 |
| 43 | Azoospermia (HP:0000027) | 3.21570298 |
| 44 | Gout (HP:0001997) | 3.17494540 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 3.11158098 |
| 46 | Ileus (HP:0002595) | 3.09801574 |
| 47 | Abnormality of serum amino acid levels (HP:0003112) | 3.09299540 |
| 48 | Steatorrhea (HP:0002570) | 3.08357977 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.96427353 |
| 50 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.95319821 |
| 51 | Metabolic acidosis (HP:0001942) | 2.88447584 |
| 52 | Spontaneous abortion (HP:0005268) | 2.87542687 |
| 53 | Myocardial infarction (HP:0001658) | 2.80919756 |
| 54 | Vascular calcification (HP:0004934) | 2.80690233 |
| 55 | Attenuation of retinal blood vessels (HP:0007843) | 2.80615697 |
| 56 | Abnormality of macular pigmentation (HP:0008002) | 2.80435608 |
| 57 | Hypochromic microcytic anemia (HP:0004840) | 2.74429533 |
| 58 | Nephritis (HP:0000123) | 2.74360025 |
| 59 | Dicarboxylic aciduria (HP:0003215) | 2.71707721 |
| 60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.71707721 |
| 61 | Lethargy (HP:0001254) | 2.71437529 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.70812408 |
| 63 | Skin nodule (HP:0200036) | 2.61835025 |
| 64 | Beaking of vertebral bodies (HP:0004568) | 2.54144082 |
| 65 | Spastic diplegia (HP:0001264) | 2.49707713 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.48811769 |
| 67 | Neonatal onset (HP:0003623) | 2.46496274 |
| 68 | Cerebral edema (HP:0002181) | 2.45332093 |
| 69 | Irritability (HP:0000737) | 2.44880676 |
| 70 | Scotoma (HP:0000575) | 2.42500016 |
| 71 | Hypoglycemic seizures (HP:0002173) | 2.41616446 |
| 72 | Male infertility (HP:0003251) | 2.40866744 |
| 73 | Generalized aminoaciduria (HP:0002909) | 2.40695260 |
| 74 | Right ventricular cardiomyopathy (HP:0011663) | 2.40380866 |
| 75 | Joint swelling (HP:0001386) | 2.39969579 |
| 76 | Malnutrition (HP:0004395) | 2.38708241 |
| 77 | Mitral stenosis (HP:0001718) | 2.38016321 |
| 78 | Hypothermia (HP:0002045) | 2.36461866 |
| 79 | Glomerulonephritis (HP:0000099) | 2.33861205 |
| 80 | Acanthocytosis (HP:0001927) | 2.33066305 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 2.32420161 |
| 82 | Exocrine pancreatic insufficiency (HP:0001738) | 2.30163973 |
| 83 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.29178390 |
| 84 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29117830 |
| 85 | Abnormal tarsal ossification (HP:0008369) | 2.28666455 |
| 86 | Alkalosis (HP:0001948) | 2.27944794 |
| 87 | Cholelithiasis (HP:0001081) | 2.27099337 |
| 88 | Sensorimotor neuropathy (HP:0007141) | 2.26687066 |
| 89 | Enlarged kidneys (HP:0000105) | 2.25716689 |
| 90 | Late onset (HP:0003584) | 2.24990569 |
| 91 | Proximal tubulopathy (HP:0000114) | 2.23418378 |
| 92 | Vomiting (HP:0002013) | 2.23409046 |
| 93 | Hyperuricemia (HP:0002149) | 2.20562555 |
| 94 | Increased purine levels (HP:0004368) | 2.20562555 |
| 95 | Potter facies (HP:0002009) | 2.20212714 |
| 96 | Facial shape deformation (HP:0011334) | 2.20212714 |
| 97 | Cholecystitis (HP:0001082) | 2.18520903 |
| 98 | Abnormal gallbladder physiology (HP:0012438) | 2.18520903 |
| 99 | Rickets (HP:0002748) | 2.16526450 |
| 100 | Abnormality of carpal bone ossification (HP:0006257) | 2.16093772 |
| 101 | Pancreatitis (HP:0001733) | 2.14638830 |
| 102 | Amyloidosis (HP:0011034) | 2.14190025 |
| 103 | Growth hormone excess (HP:0000845) | 2.13095980 |
| 104 | Esophageal varix (HP:0002040) | 2.12083225 |
| 105 | Arthropathy (HP:0003040) | 2.11931010 |
| 106 | Abnormal spermatogenesis (HP:0008669) | 2.11062651 |
| 107 | Abnormal hemoglobin (HP:0011902) | 2.08468937 |
| 108 | Abnormality of proline metabolism (HP:0010907) | 2.07772040 |
| 109 | Hydroxyprolinuria (HP:0003080) | 2.07772040 |
| 110 | Brushfield spots (HP:0001088) | 2.05793024 |
| 111 | Gingival bleeding (HP:0000225) | 2.05380835 |
| 112 | Menorrhagia (HP:0000132) | 2.05231889 |
| 113 | Opisthotonus (HP:0002179) | 2.04908558 |
| 114 | Thrombophlebitis (HP:0004418) | 2.04133969 |
| 115 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.01503216 |
| 116 | Chronic hepatic failure (HP:0100626) | 1.99291112 |
| 117 | Glycosuria (HP:0003076) | 1.96892241 |
| 118 | Abnormality of urine glucose concentration (HP:0011016) | 1.96892241 |
| 119 | Increased serum ferritin (HP:0003281) | 1.96731808 |
| 120 | Hypophosphatemic rickets (HP:0004912) | 1.95175000 |
| 121 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95152565 |
| 122 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.95088217 |
| 123 | Abnormality of the gallbladder (HP:0005264) | 1.93572245 |
| 124 | Fair hair (HP:0002286) | 1.92704547 |
| 125 | Hemorrhage of the eye (HP:0011885) | 1.91002488 |
| 126 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89710717 |
| 127 | Neonatal death (HP:0003811) | 1.89343915 |
| 128 | Severe Myopia (HP:0011003) | 1.88757209 |
| 129 | Abnormality of iron homeostasis (HP:0011031) | 1.88030142 |
| 130 | Abnormal cartilage morphology (HP:0002763) | 1.87685070 |
| 131 | Abnormal hand bone ossification (HP:0010660) | 1.86141375 |
| 132 | Pulmonary embolism (HP:0002204) | 1.85097265 |
| 133 | Neoplasm of head and neck (HP:0012288) | 1.84584360 |
| 134 | Esophageal neoplasm (HP:0100751) | 1.84584360 |
| 135 | Reticulocytosis (HP:0001923) | 1.83261031 |
| 136 | Bile duct proliferation (HP:0001408) | 1.83104082 |
| 137 | Abnormal biliary tract physiology (HP:0012439) | 1.83104082 |
| 138 | Poikilocytosis (HP:0004447) | 1.82244512 |
| 139 | Testicular neoplasm (HP:0010788) | 1.82139963 |
| 140 | Tubulointerstitial nephritis (HP:0001970) | 1.81816326 |
| 141 | Renal cortical cysts (HP:0000803) | 1.81365964 |
| 142 | Abnormality of secondary sexual hair (HP:0009888) | 1.80182585 |
| 143 | Abnormality of the axillary hair (HP:0100134) | 1.80182585 |
| 144 | Epiphyseal stippling (HP:0010655) | 1.79105020 |
| 145 | Generalized hypopigmentation of hair (HP:0011358) | 1.77842805 |
| 146 | Neoplasm of the lung (HP:0100526) | 1.76552188 |
| 147 | Submucous cleft hard palate (HP:0000176) | 1.75439791 |
| 148 | Prolonged bleeding time (HP:0003010) | 1.75151306 |
| 149 | Congenital sensorineural hearing impairment (HP:0008527) | 1.75141196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.31160683 |
| 2 | LMTK2 | 5.59821720 |
| 3 | FGFR4 | 4.60502418 |
| 4 | AKT3 | 4.49656703 |
| 5 | ERN1 | 4.26330649 |
| 6 | SIK1 | 4.22177198 |
| 7 | PIK3CA | 3.78554134 |
| 8 | TAOK3 | 2.95512510 |
| 9 | ERBB4 | 2.92149314 |
| 10 | INSRR | 2.85771369 |
| 11 | TNK2 | 2.72612556 |
| 12 | MST1R | 2.21836382 |
| 13 | MAP2K4 | 2.20006168 |
| 14 | ILK | 2.03499503 |
| 15 | PKN2 | 1.93152556 |
| 16 | MYLK | 1.93136964 |
| 17 | MAPK11 | 1.91444579 |
| 18 | STK39 | 1.76037530 |
| 19 | PIK3CG | 1.74616101 |
| 20 | TRIB3 | 1.68015307 |
| 21 | FLT3 | 1.65385372 |
| 22 | LATS1 | 1.61627083 |
| 23 | DAPK2 | 1.57604844 |
| 24 | TYK2 | 1.57263884 |
| 25 | FER | 1.48271225 |
| 26 | ABL2 | 1.46553097 |
| 27 | PTK6 | 1.46370345 |
| 28 | CDK12 | 1.44932270 |
| 29 | PIM2 | 1.41744237 |
| 30 | STK38L | 1.40824490 |
| 31 | NEK9 | 1.33367878 |
| 32 | NTRK3 | 1.32081498 |
| 33 | FRK | 1.31689523 |
| 34 | MAP3K12 | 1.31161992 |
| 35 | FGFR2 | 1.29604530 |
| 36 | WNK3 | 1.28640265 |
| 37 | MAP3K7 | 1.26414243 |
| 38 | PINK1 | 1.25937079 |
| 39 | JAK2 | 1.19463561 |
| 40 | KDR | 1.17259880 |
| 41 | GRK6 | 1.17042000 |
| 42 | MARK2 | 1.14152751 |
| 43 | WNK4 | 1.13537045 |
| 44 | DMPK | 1.13258601 |
| 45 | EIF2AK1 | 1.12560325 |
| 46 | PRKAA2 | 1.10848454 |
| 47 | BRSK2 | 1.08275093 |
| 48 | NUAK1 | 1.03649118 |
| 49 | MAP2K3 | 1.00827264 |
| 50 | MAP4K2 | 1.00217529 |
| 51 | ERBB2 | 0.99659719 |
| 52 | RIPK4 | 0.99205843 |
| 53 | MAP3K14 | 0.98465294 |
| 54 | TNIK | 0.98003276 |
| 55 | TBK1 | 0.96658619 |
| 56 | EPHB1 | 0.96648513 |
| 57 | PRKD2 | 0.95883904 |
| 58 | SGK1 | 0.94578013 |
| 59 | PRKCZ | 0.92604480 |
| 60 | JAK1 | 0.92360814 |
| 61 | BMPR1B | 0.92300429 |
| 62 | BRD4 | 0.92086834 |
| 63 | EIF2AK3 | 0.90470256 |
| 64 | MAPK4 | 0.89929121 |
| 65 | TIE1 | 0.89627916 |
| 66 | NME1 | 0.89180314 |
| 67 | PLK4 | 0.89028704 |
| 68 | MAPK15 | 0.88277769 |
| 69 | CDK9 | 0.87356423 |
| 70 | MAP3K3 | 0.86848461 |
| 71 | HIPK2 | 0.85963647 |
| 72 | WNK1 | 0.85548718 |
| 73 | NEK6 | 0.84868417 |
| 74 | MAP3K10 | 0.84734215 |
| 75 | MET | 0.84431676 |
| 76 | OXSR1 | 0.84291638 |
| 77 | SGK3 | 0.80596078 |
| 78 | DYRK1B | 0.79826814 |
| 79 | MAPK12 | 0.77561835 |
| 80 | GSK3A | 0.74946980 |
| 81 | PRKACG | 0.74549665 |
| 82 | MAP3K11 | 0.73664724 |
| 83 | TESK1 | 0.71275230 |
| 84 | PRKAA1 | 0.70373525 |
| 85 | CDK6 | 0.69006169 |
| 86 | SGK494 | 0.68734730 |
| 87 | SGK223 | 0.68734730 |
| 88 | PRKG2 | 0.68530898 |
| 89 | EPHA3 | 0.68291436 |
| 90 | CAMK2G | 0.67586787 |
| 91 | IRAK3 | 0.67270448 |
| 92 | SGK2 | 0.66001019 |
| 93 | BTK | 0.65883003 |
| 94 | TGFBR2 | 0.64338916 |
| 95 | CSK | 0.63895400 |
| 96 | NLK | 0.63871273 |
| 97 | MAP2K6 | 0.63598252 |
| 98 | PTK2 | 0.62876409 |
| 99 | STK24 | 0.62787571 |
| 100 | JAK3 | 0.61706299 |
| 101 | TAOK1 | 0.61604476 |
| 102 | PRKD1 | 0.60399100 |
| 103 | RIPK1 | 0.59634326 |
| 104 | RPS6KB2 | 0.58441223 |
| 105 | TRPM7 | 0.57938483 |
| 106 | ERBB3 | 0.57367148 |
| 107 | PDK3 | 0.57185487 |
| 108 | PDK4 | 0.57185487 |
| 109 | RPS6KA4 | 0.56938496 |
| 110 | PDPK1 | 0.56537690 |
| 111 | CAMK1D | 0.55845877 |
| 112 | FGFR3 | 0.52917095 |
| 113 | TEC | 0.52683956 |
| 114 | CAMK1G | 0.51660813 |
| 115 | YES1 | 0.50271399 |
| 116 | MARK3 | 0.50233004 |
| 117 | MAPK3 | 0.50103232 |
| 118 | MAPK7 | 0.49884580 |
| 119 | PRKCQ | 0.48216985 |
| 120 | IKBKE | 0.47936304 |
| 121 | EPHA4 | 0.47798733 |
| 122 | PRKG1 | 0.47778241 |
| 123 | RPS6KA5 | 0.46902546 |
| 124 | CSF1R | 0.45976500 |
| 125 | LRRK2 | 0.44197680 |
| 126 | CSNK1G1 | 0.43813645 |
| 127 | IGF1R | 0.42406588 |
| 128 | RAF1 | 0.41897118 |
| 129 | MAPK10 | 0.40691732 |
| 130 | PKN1 | 0.40109228 |
| 131 | GRK1 | 0.39536453 |
| 132 | STK11 | 0.39529881 |
| 133 | PRKACA | 0.39209915 |
| 134 | ADRBK2 | 0.38827266 |
| 135 | RPS6KA3 | 0.38447014 |
| 136 | MAP2K1 | 0.38099531 |
| 137 | PRKCG | 0.37838791 |
| 138 | MAP3K13 | 0.36457375 |
| 139 | MAP3K5 | 0.36396384 |
| 140 | MINK1 | 0.35694956 |
| 141 | TAOK2 | 0.35288676 |
| 142 | ICK | 0.34762227 |
| 143 | CSNK1E | 0.34697151 |
| 144 | PRKCE | 0.34235405 |
| 145 | MTOR | 0.34200246 |
| 146 | PDK1 | 0.34092578 |
| 147 | RET | 0.33479523 |
| 148 | EGFR | 0.32516141 |
| 149 | CAMK4 | 0.31004718 |
| 150 | NEK1 | 0.30523578 |
| 151 | IRAK2 | 0.30395924 |
| 152 | CDK4 | 0.29896641 |
| 153 | IRAK1 | 0.29860277 |
| 154 | STK38 | 0.29289692 |
| 155 | MAP3K6 | 0.28211073 |
| 156 | PRKCA | 0.27338153 |
| 157 | PAK3 | 0.25354335 |
| 158 | MAP3K1 | 0.24041395 |
| 159 | PBK | 0.23102179 |
| 160 | PDK2 | 0.21950542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.43162938 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.42119324 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.41767298 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29878011 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97460766 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73893223 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.71978734 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.63251778 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61216854 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54792555 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50255809 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47569653 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.35960444 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.16985362 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15612147 |
| 16 | * Butanoate metabolism_Homo sapiens_hsa00650 | 2.09437257 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03284689 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94695430 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92435815 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89700875 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87690813 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83393232 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80382502 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.75609348 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75431312 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73610313 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69492297 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67666533 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66389407 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65674699 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.65076858 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.63892973 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58904550 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.54137360 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54045215 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45528739 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41879656 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40921542 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39136032 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30513027 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28693068 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27772315 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.25499372 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21995197 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19548479 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17409846 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16362044 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15993048 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.15220661 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06837650 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03017271 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01602421 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00686426 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97545537 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95501078 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94865513 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92972657 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91857366 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.85876098 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84821284 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78657582 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74659504 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71050988 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70084909 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68545521 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62130235 |
| 67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61827220 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57633179 |
| 69 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46713969 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45044949 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37931534 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.33000899 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28247281 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.25210648 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.25208062 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24086955 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22559547 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.21490744 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19879553 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19549099 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16734693 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.15113101 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11831068 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.11446488 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.10180348 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.10024875 |
| 87 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.09759456 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08139330 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.05113492 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.04754216 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.01300679 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.01254983 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.01087233 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00931771 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.00291499 |
| 96 | Lysosome_Homo sapiens_hsa04142 | -0.2290355 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | -0.2269453 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | -0.2143927 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2082974 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2026971 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1905333 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1900912 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1742823 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1723326 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1721445 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | -0.1692843 |
| 107 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1413763 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1347702 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1293235 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1207004 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1197103 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1196080 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0975960 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0946460 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0902899 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0333933 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0188395 |
| 118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0178279 |
| 119 | Tight junction_Homo sapiens_hsa04530 | -0.0152008 |

